Cassandra Kelly-Cirino | OMICS International
ISSN: 2157-2526

Journal of Bioterrorism & Biodefense
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google scholar citation report
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Cassandra Kelly-Cirino

 New York university school of medicine USA


 Dr. Cassandra Kelly-Cirino has over 16 years experience working in Canadian and US public health laboratories. Cassandra began her career at the Canadian National Microbiology Laboratory in Winnipeg working on various infectious diseases including prions. In her 10-year tenure at the Wadsworth Center, New York State Department of Health, Cassandra served as the Deputy Director of the Biodefense Laboratory, a heavily regulated and accredited laboratory. During this time Cassandra also completed a Ph.D. in Immunology and Infectious Diseases and developed vaccine and passive immunotherapeutic candidates for anthrax infections. Dr. Kelly-Cirino engaged national and international stakeholders in the development of public health policy for infectious diseases with a focus on emergency response and preparedness, developed novel diagnostic assays for multiple pathogens, and served as third-party evaluator for commercial companies developing novel tools to combat infectious diseases. Most recently, Dr. Kelly-Cirino joined DNA Genotek, a Canadian company known for its sample stabilization and collection technologies. In her current role as Vice President of Infectious Diseases, Cassandra leads multiple initiatives to bring simple collection and stabilization solutions to the global public health and emergency response fields. Dr. Kelly-Cirino’s extensive experience in public health has enabled her to design solutions that are well suited to infectious disease response during routine and outbreak situations.

Research Interest

 Infectious Disesases